Medicare Enrolled
Dr. Philip Ayvazian, MD
Urology Physician · Worcester, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ayvazian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ayvazian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ayvazian
Dr. Philip Ayvazian is an urology physician in Worcester, MA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ayvazian performed 4,857 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ayvazian received a total of $4,083 from 40 pharmaceutical and/or device companies across 193 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ayvazian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 22% volume in MA
$4,083 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,857
Medicare services
Top 22% in MA for urology physician
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,142 | $3 | $20 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
1,140 | $5 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,118 | $93 | $250 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
455 | $8 | $65 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
250 | $88 | $340 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
181 | $200 | $600 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
125 | $20 | $35 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $133 | $502 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $117 | $390 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $72 | $175 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
38 | $115 | $625 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
37 | $28 | $105 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $203 | $525 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $117 | $362 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
22 | $49 | $500 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $6 | $185 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
18 | $259 | $688 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
16 | $335 | $1,200 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
16 | $77 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
19.5% medium
79.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,083
Total received (2018-2024)
Avg $583/year across 7 years
Top 32% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
193
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$829
2023
$852
2022
$682
2021
$154
2020
$429
2019
$490
2018
$647
Payments by company (2024)
Merck Sharp & Dohme LLC
$145
Janssen Biotech, Inc.
$125
Sumitomo Pharma America, Inc.
$92
Astellas Pharma US Inc
$88
Ferring Pharmaceuticals Inc.
$85
PFIZER INC.
$59
ABBVIE INC.
$55
UROGEN PHARMA, INC.
$42
ConvaTec Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$29
Axonics, Inc.
$25
PROGENICS PHARMACEUTICALS, INC.
$23
Myriad Genetic Laboratories, Inc.
$19
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$963
Janssen Biotech, Inc.
$334
PFIZER INC.
$322
Merck Sharp & Dohme LLC
$293
Endo Pharmaceuticals Inc.
$194
Sumitomo Pharma America, Inc.
$175
Bayer Healthcare Pharmaceuticals Inc.
$162
PROCEPT BioRobotics Corporation
$119
AbbVie Inc.
$114
Ferring Pharmaceuticals Inc.
$113
AbbVie, Inc.
$101
ABBVIE INC.
$91
ConvaTec Inc.
$88
Axonics, Inc.
$71
Avadel Specialty Pharmaceuticals, LLC
$67
Merck Sharp & Dohme Corporation
$61
Myriad Genetic Laboratories, Inc.
$60
Boston Scientific Corporation
$55
Teleflex LLC
$53
Bayer HealthCare Pharmaceuticals Inc.
$49
Accord Healthcare, Inc.
$47
Myovant Sciences Inc.
$47
Novartis Pharmaceuticals Corporation
$47
Rochester Medical Corporation
$43
UROGEN PHARMA, INC.
$42
Progenics Pharmaceuticals, Inc.
$40
Acerus Pharmaceuticals Corporation
$39
Coloplast Corp
$33
180 Medical, Inc.
$29
Otsuka America Pharmaceutical, Inc.
$27
Supernus Pharmaceuticals, Inc.
$27
Blue Earth Diagnostics Limited
$24
PROGENICS PHARMACEUTICALS, INC.
$23
TOLMAR Pharmaceuticals, Inc.
$21
Aytu BioScience, Inc
$20
UROVANT SCIENCES INC
$19
Antares Pharma, Inc.
$18
Mission Pharmacal Company
$18
Dendreon Pharmaceuticals LLC
$17
Kowa Pharmaceuticals America, Inc.
$16
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BOTOX · BRIDION · Bulkamid · CAMCEVI · CONTINENCE CARE · CURE CATHETER · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENTLECATH · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · Lithostat · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Rezum Generator · SEGLENTIS · SPEEDICATH · TOVIAZ · UROLIFT · XIAFLEX · XTANDI · XYOSTED · Xtandi · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
41
County median income
$93,561
Nearest hospital to ZIP centroid (approximate)
ADCARE HOSPITAL OF WORCESTER INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ayvazian is a clinical cardiology specialist, with above-average Medicare volume (top 22% in MA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ayvazian experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Ayvazian performed 1,142 urinalysis with microscopic exam services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ayvazian receive payments from pharmaceutical companies?
Yes. Dr. Ayvazian received a total of $4,083 from 40 companies across 193 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ayvazian's costs compare to other urology physicians in Worcester?
Dr. Ayvazian's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ayvazian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Worcester
Browse urology physicians in Worcester ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology